(Page 2 of 2)
the board meetings of PatientSafe Solutions. Psilos was a lead investor in the startup, which provides handheld devices that help reduce hospital medication errors. Suennen said her firm invests in health IT, healthcare services, and medical technologies.
—San Diego-based MabVax Therapeutics got a $1.1-million follow-on grant from the Small Business Technology Transfer Program of the National Cancer Institute. The privately held company is developing a human monoclonal antibody therapy to target a specific antigen expressed by colon, pancreatic, and breast cancer cells.
—San Diego-based Orphagen Pharmaceuticals said it got a two-year, $520,000 grant from the National Cancer Institute through its Small Business Innovative Research (SBIR) program to develop a new class of drugs for treating adrenocortical and prostate cancer.